The sparseness of our data set precludes us from doing a fully factorial analysis of mutations, drugs, and species.
Although the small sample size of retroposed duplicates within our data set precludes a robust explanation for this trend, we speculate that this pattern may represent a burst of retrotranspositional activity yielding gene duplicates in our species' recent evolutionary past.
In the current case, the absence of both name and a common person identifier on both of the data sets precludes linking data using either of these approaches.
As shown in Table 2, except for those three associations, limitations in our data set preclude the analysis to detect further associations due to the lack of sufficient statistical power.
In the data set of eQTLs used in our analysis, only a small fraction (<5%) are trans-eQTLs, precluding our analyses with trans-eQTLs.
The combination of small sample size and incomplete data sets precludes robust statistical assessment of the impact of DrotAA treatment on either mortality or SBE and ICH incidence in patients with PF, MEN, or MD.
However, as noted above, the data given in data set 3 preclude the presence of a double bond in, or on the labdanoid A/B ring system in mature samples.
The data sets were sorted by result number to preclude anything with a result number of >50 (this means that there are 49 other structures in the PDB database that this protein is more similar to).
However, most of the data sets used in this report contained only one non-control dose, precluding the extensive dose response modeling that would be required to estimate this ratio of doses.
It should be noted that significant spectral overlap at 8 M urea and high NaCl concentrations precluded the extraction of a complete PRE data set.
